Supplemental materials for the review "Levothyroxine: Impaired bioavailability and novel drug delivery formulations"

Published: 24 March 2022| Version 1 | DOI: 10.17632/xsz6d54tjb.1
Contributor:
Ben Tsing

Description

Supplemental materials for the review "Levothyroxine: Impaired bioavailability and novel drug delivery formulations" Supplementary table 1. Summary of clinical studies evaluating the bioavailability of liquid LT4 and soft gel capsule in cases with interfering factors. Supplementary table 2. Summary of application of nanomaterials in the drug delivery of levothyroxine. Supplementary figure 1. The flow chart of included articles.

Files

Steps to reproduce

The authors collected the data from the articles listed in the references.

Institutions

Wuhan University Renmin Hospital, Wuhan University

Categories

Peer Review

Licence